AirStrip Technologies, an enterprise AI healthcare technology company, entered into a committed $50 million credit facility with OrbiMed, a global healthcare investment firm. OrbiMed also made a preferred stock investment in AirStrip. BTIG acted as exclusive placement agent and strategic advisor for the transaction.
The funding will accelerate AirStrip’s growth strategy as demand increases for its solutions in patient monitoring, clinical surveillance, decision support and alarm management. Proceeds will be used to expand product innovation, scale go-to-market initiatives and drive rapid deployment across health systems and hospitals nationwide.
“This funding will accelerate our transformation of how clinicians access and act on critical clinical information,” Haris Naseem, CEO of AirStrip, said. “We’re unifying fragmented data and delivering timely, actionable insights to facilitate improved decision-making and enhanced patient safety at every stage of care.”
Matthew Rizzo, general partner of OrbiMed, added, “OrbiMed seeks to partner with companies that deliver meaningful, sustainable impacts in healthcare. AirStrip is a proven leader with tremendous potential, and we’re excited to participate in their next phase of growth and innovation.”
